Bersacapavir is an HBV capsid assembly modulator. Bersacapavir exerts a dual mechanism of action against both early and late stages of HBV infection by forming complete genome-free empty capsids and inhibiting de novo synthesis of cccDNA. Bersacapavir inhibits HBV replication. Bersacapavir can be used in the research of hepatitis B[1].
Molecular Weight:
418.37
Purity:
98.90
CAS Number:
[1638266-40-6]
Formula:
C16H14F4N4O3S
Target:
DNA/RNA Synthesis,HBV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted